Safety Alerts & Recalls

Search all Safety Alerts & Recalls

Latest Alerts

B. Braun Recalls Several Lots of Heparin
B. Braun Medical Inc. (B. Braun) is issuing a nationwide recall of Heparin because testing of samples of the active ingredient found trace amounts of the contaminant oversulfated chondroitin sulfate. B. Braun has not received any reports of adverse events regarding B. Braun finished heparin products. However, as a precaution B. Braun is initiating a voluntary recall of seven lots of heparin injection products to the healthcare provider level. These lots were manufactured in 2008 and will be expiring on October 31, 2010 and November 30, 2010. The following B. Braun products and lot numbers have been recalled: 25,000 Units Heparin in 5% Dextrose Injection, 50 Units/mL, lot numbers J8D674 and J8E462 1,000 Units Heparin in 0.9% Sodium Chloride Injection, 2 Units/mL, lot numbers J8D676, J8D677, J8D702, J8D703, and J8E539 Heparin is a blood thinner used to treat and prevent blood clots For more information, please visit:
Learn More

Discontinuation of Original Prefilled Pens for Humalog and Humalog Mix
As of January 1, 2011, Lilly will no longer manufacture the original Prefilled Pens that contain: Humalog (insulin lispro injection [rDNA origin]) Humalog Mix 75/25 (75% insulin lispro protamine suspension, 25% insulin lispro injection [rDNA origin]), and Humalog Mix 50/50 (50% insulin lispro protamine suspension, 50% insulin lispro injection [rDNA origin]). This action is being taken in an effort to align Humalog prefilled devices under a single pen platform. By the end of October 2010, it is expected that the original Prefilled Pen containing Humalog Mix50/50 will no longer be available to pharmacies and healthcare providers. At this time, the original Prefilled Pen containing Humalog or Humalog Mix75/25 continues to be available, and pharmacies and healthcare providers can order and dispense these to patients until supplies are exhausted. There are several brands and formulations of insulin available. This discontinuation alert only applies to the original Prefilled Pen that contains Humalog, Humalog Mix 75/25, and Humalog Mix 50/50. The Humalog brand of insulin will continue to be available in other delivery options including a pen device called the KwikPen. To learn more about the discontinuation of these products and the available KwikPen Product, please visit: Humalog Pen - Humalog Mix 75/25 Pen - Humalog Mix 50/50 Pen -
Learn More

Date Published Title Drug Source
2010-11-01 B. Braun Recalls Several Lots of Heparin Heparin FDA
2010-11-03 Discontinuation of Original Prefilled Pens for Humalog and Humalog Mix Insulin Lispro and Insulin Lispro Protamine Manufacturer
2010-11-04 Blenheim Pharmacal Recalls Sulfamethoxazole and Trimethoprim DS Tablets Sulfamethoxazole with Trimethoprim FDA
2010-11-04 Medical Products Laboratories, Inc. Recalls Single Lot of NaFrinse Sodium Fluoride FDA
2010-11-04 Actavis Issues Consumer Update to Recall of Fentanyl Transdermal System 25 mcg/h Patches Fentanyl Manufacturer
2010-11-05 Vitamin E Linked to Certain Types of Stroke MediGuard CRT
2010-11-19 FDA Recommends Against the Continued Use of Propoxyphene (Darvon, Darvocet, and Others) Propoxyphene HCl FDA
2010-11-24 McNeil Issues Another Recall: Junior Strength Motrin Caplets Ibuprofen Manufacturer
2010-11-24 McNeil Issues Another Recall: Rolaids Extra Strength Softchews Calcium Carbonate with Magnesium Hydroxide Manufacturer
2010-11-24 McNeil Issues Another Recall: Children's Benadryl Allergy Fastmelt Tablets Diphenhydramine Manufacturer
2010-11-29 Vintage and Qualitest Pharmaceuticals Recall a Single Lot of Prednisone Tamoxifen FDA
2010-11-29 Teva Recalls Single Lot of Tamoxifen Tamoxifen FDA
2010-11-29 McNeil Issues Another Recall: Tylenol Cold Multi-Symptom Liquid Products Tylenol Cold Multisymtom Plus Coug Manufacturer
2010-12-02 Johnson and Johnson Recalls Several Mylanta and AlternaGel Liquid Products FDA
2010-12-10 McNeil Now Recalls All Lots of Three Rolaids Heartburn Products Calcium Carbonate with Magnesium Hydroxide Manufacturer
2010-12-13 Reese Pharmaceutical Company Recalls Certain Over-The-Counter Cold Relief Products That Are Mislabeled Guaifenesin Manufacturer
2010-12-14 Accidental Ingestion of Benzonatate (Tessalon) By Children Can Result in Serious Adverse Effects Benzonatate FDA
2010-12-16 FDA Begins Process To Remove Breast Cancer Indication From Avastin Prescribing Information Label Bevacizumab FDA
2010-12-20 FDA Publishes Drug Safety Communication: Abnormal Heart Rhythms Associated With Use of Anzemet (Dolasetron Mesylate) Dolasetron FDA
2010-12-21 Pfizer Recalls More Bottles of Lipitor Over Strange Smell Atorvastatin Manufacturer